• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞在非小细胞肺癌中的临床意义及潜在治疗靶点

The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer.

作者信息

Sun Jiazheng, Zhou Sirui, Sun Yalu, Zeng Yulan

机构信息

Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Affiliated Hospital of Jining Medical University, Jining, China.

出版信息

Front Med (Lausanne). 2025 Apr 30;12:1541104. doi: 10.3389/fmed.2025.1541104. eCollection 2025.

DOI:10.3389/fmed.2025.1541104
PMID:40370720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12076932/
Abstract

One of the leading causes of cancer-related mortality globally is non-small cell lung cancer (NSCLC). It has become a significant public health concern due to its rising incidence rate and fatality. Tumor-associated macrophage (TAM) is important in the tumor microenvironment (TME) of NSCLC because they have an impact on the development, metastasis, and incidence of tumors. As a crucial element of the TME, TAM contributes to tumor immune evasion, facilitates tumor proliferation and metastasis, and modulates tumor angiogenesis, immunosuppression, and treatment resistance through the secretion of diverse cytokines, chemokines, and growth factors. Consequently, TAM assumes a multifaceted and intricate function in the onset, progression, and therapeutic response of NSCLC, serving as a crucial focal point for comprehending the tumor microenvironment and formulating novel therapeutic methods. The study aims to review the biological properties and potential processes of TAM in NSCLC, investigate its involvement in the clinical of NSCLC patients, and discuss its potential as a therapeutic target.

摘要

全球与癌症相关的死亡的主要原因之一是非小细胞肺癌(NSCLC)。由于其发病率和死亡率不断上升,它已成为一个重大的公共卫生问题。肿瘤相关巨噬细胞(TAM)在NSCLC的肿瘤微环境(TME)中很重要,因为它们对肿瘤的发展、转移和发生有影响。作为TME的关键要素,TAM通过分泌多种细胞因子、趋化因子和生长因子,促进肿瘤免疫逃逸,推动肿瘤增殖和转移,并调节肿瘤血管生成、免疫抑制和治疗抗性。因此,TAM在NSCLC的发生、发展和治疗反应中发挥着多方面且复杂的作用,是理解肿瘤微环境和制定新治疗方法的关键焦点。该研究旨在综述TAM在NSCLC中的生物学特性和潜在过程,研究其在NSCLC患者临床中的参与情况,并讨论其作为治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/12076932/98c49c451139/fmed-12-1541104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/12076932/98c49c451139/fmed-12-1541104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/12076932/98c49c451139/fmed-12-1541104-g001.jpg

相似文献

1
The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer.肿瘤相关巨噬细胞在非小细胞肺癌中的临床意义及潜在治疗靶点
Front Med (Lausanne). 2025 Apr 30;12:1541104. doi: 10.3389/fmed.2025.1541104. eCollection 2025.
2
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.解决非小细胞肺癌中的 CPI 耐药性:靶向 TAM 受体调节肿瘤微环境和未来前景。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004863.
3
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.ILT4 抑制可预防 TAM 和功能失调 T 细胞介导的免疫抑制,并增强 EGFR 激活的 NSCLC 中抗 PD-L1 治疗的疗效。
Theranostics. 2021 Jan 19;11(7):3392-3416. doi: 10.7150/thno.52435. eCollection 2021.
4
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation.胆碱代谢重编程通过促进肿瘤相关巨噬细胞功能极化和内皮细胞增殖来介导非小细胞肺癌(NSCLC)中的免疫抑制微环境。
J Transl Med. 2024 May 10;22(1):442. doi: 10.1186/s12967-024-05242-3.
5
Comprehensive Integrative Analysis Reveals the Association of with Macrophage Infiltration and Polarization in Lung Cancer Microenvironment.全面综合分析揭示与肺癌微环境中巨噬细胞浸润和极化的关联。
Cells. 2021 Aug 14;10(8):2091. doi: 10.3390/cells10082091.
6
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.免疫抑制型 TREM2(+) 巨噬细胞与非小细胞肺癌的不良预后和对 PD-1 免疫治疗的反应相关。
Cancer Immunol Immunother. 2022 Oct;71(10):2511-2522. doi: 10.1007/s00262-022-03173-w. Epub 2022 Mar 12.
7
ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis.整合素β4/鸟嘌呤核苷酸结合蛋白β5轴促进非小细胞肺癌转移中的M2巨噬细胞重编程。
Int Immunopharmacol. 2025 Jan 10;144:113564. doi: 10.1016/j.intimp.2024.113564. Epub 2024 Nov 22.
8
Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.IFN-γ 对 IA 期非小细胞肺癌免疫微环境及 TAM 极性的影响及其机制。
BMC Pulm Med. 2024 Jan 22;24(1):46. doi: 10.1186/s12890-023-02809-6.
9
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk.巨噬细胞与肿瘤细胞的相互作用是肺肿瘤进展的基础:我们需要探讨。
Front Oncol. 2020 Mar 11;10:324. doi: 10.3389/fonc.2020.00324. eCollection 2020.
10
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.CXCR4 抑制作用可逆转转移性 NSCLC 干细胞的免疫抑制特性。
Front Immunol. 2020 Oct 2;11:02168. doi: 10.3389/fimmu.2020.02168. eCollection 2020.

本文引用的文献

1
P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior.巨噬细胞极化中的P2X7受体及其对神经母细胞瘤肿瘤行为的影响。
Purinergic Signal. 2025 Feb;21(1):51-68. doi: 10.1007/s11302-024-10051-w. Epub 2024 Oct 19.
2
Ultrasound-Responsive Nanocarriers Delivering siRNA and FeO Nanoparticles Reprogram Macrophages and Inhibit M2 Polarization for Enhanced NSCLC Immunotherapy.超声响应纳米载体递呈 siRNA 和 FeO 纳米颗粒重编程巨噬细胞并抑制 M2 极化增强 NSCLC 免疫治疗。
ACS Appl Mater Interfaces. 2024 Oct 23;16(42):56634-56652. doi: 10.1021/acsami.4c10036. Epub 2024 Oct 8.
3
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment.
肺癌微环境中肿瘤相关巨噬细胞极化调控信号通路的研究进展。
Front Immunol. 2024 Jul 31;15:1452078. doi: 10.3389/fimmu.2024.1452078. eCollection 2024.
4
New promises and challenges in the treatment of advanced non-small-cell lung cancer.晚期非小细胞肺癌治疗的新承诺和新挑战。
Lancet. 2024 Aug 24;404(10454):803-822. doi: 10.1016/S0140-6736(24)01029-8. Epub 2024 Aug 6.
5
The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors.二氢丹参酮 I 治疗肿瘤的多方面机制。
Biomed Pharmacother. 2024 Jun;175:116635. doi: 10.1016/j.biopha.2024.116635. Epub 2024 Apr 22.
6
IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.肿瘤相关巨噬细胞中的 IL6-STAT3-C/EBPβ-IL6 正反馈环促进肺腺癌的 EMT 和转移。
J Exp Clin Cancer Res. 2024 Feb 29;43(1):63. doi: 10.1186/s13046-024-02989-x.
7
Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation.重楼七叶皂苷 VII 通过调节 EGFR 通路诱导 CTC 失巢凋亡抑制肺癌转移。
Int J Biol Sci. 2023 Oct 16;19(16):5204-5217. doi: 10.7150/ijbs.83682. eCollection 2023.
8
Jin-Fu-An decoction manipulation of macrophage polarization via β-catenin (CTNNB1) synergizes with cisplatin in lung cancer.金复安汤通过β-连环蛋白(CTNNB1)调控巨噬细胞极化与顺铂协同作用治疗肺癌。
Biomed Pharmacother. 2023 Dec;168:115828. doi: 10.1016/j.biopha.2023.115828. Epub 2023 Nov 3.
9
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.MUC1-C是NSCLC中获得性奥希替尼耐药的常见驱动因素。
J Thorac Oncol. 2024 Mar;19(3):434-450. doi: 10.1016/j.jtho.2023.10.017. Epub 2023 Nov 3.
10
Recent advances in liposome-based targeted cancer therapy.基于脂质体的靶向癌症治疗的最新进展。
J Liposome Res. 2024 Jun;34(2):316-334. doi: 10.1080/08982104.2023.2268710. Epub 2023 Oct 17.